ArticleCancers2020

Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy.

Chara Papadaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.